Library
MDPEP
MDPEP is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug. It is the longer chain heptyl homologue of the well known stimulant designer drugs MDPV and MDPHP. It was first identified in Sweden in 2019 and has been relatively widely sold, being the most commonly encountered substituted cathinone derivative found in the US in 2020–2021, though it has still not reached the same levels of use internationally as MDPV and MDPHP.
Also known as: 3,4-metilendioxi-PV8
Classification
- Chemical: Cathinone
- Psychoactive: Stimulant
- Tag: Pyrrolidinophenone
- Tag: Synthetic cathinone
Effects
- Increased Heart Rate
- Stimulation
- Insomnia
- Vasoconstriction
- Jaw Tension
- Loss Of Appetite
- Talkativeness
- Alertness Enhancement
- Euphoria
- Anxiety
- Paranoia
- Motivation Enhancement
- Light Sensitivity
- Tactile Enhancement
- Appetite Suppression
- Increased Libido
- Disinhibition
- Dehydration
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
